Parenting in the NICU Coping With the NICU Experience Family and Friends Leaving the NICU Grief & Loss Glossary March of Dimes Helps Prematurity Home MedImmune, Inc. MedImmune, Inc., is a leading biotechnology company focused on researching, developing, and commercializing products to prevent or treat infectious disease, autoimmune disease, and cancer. MedImmune actively markets four products—Synagis(R) (palivizumab), Ethyol(R) (amifostine), FluMist(TM) (influenza virus vaccine live, intranasal), and CytoGam(R) (cytomegalovirus immune globulin intravenous, human)—and has additional products in clinical testing. MedImmune employs approximately 1,800 people, is headquartered in Gaithersburg, Maryland, and has additional operations in Frederick, Maryland, as well as Pennsylvania, California, the United Kingdom, and the Netherlands. For more information on MedImmune and its products, visit the company's Web site at www.medimmune.com. March of Dimes Share. An online community serving NICU families. Share your story and meet other NICU families. Information specialists at the March of Dimes help answer your questions by e-mail and online chat.
	Home | Editorial Policy | Terms of Use | Privacy Policy | Link Policy | Contact Us | nacersano.org © 2009 March of Dimes Birth Defects Foundation. All rights reserved. The March of Dimes is a not-for-profit organization recognized as tax-exempt under Internal Revenue Code section 501(c)(3). Our mission is to improve the health of babies by preventing birth defects and infant mortality.